Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-24

Clinical Trial Update: Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing Tilmanocept to sulfur colloid for sentinel lymph node biopsy in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfur Colloid (Sulfur colloid)
  • Tilmanocept (Tilmanocept)

Snippet

Sponsor: Memorial Health University Medical Center | Conditions: Sentinel Lymph Node Biopsy, Breast Cancer | Phase 4 | Status: UNKNOWN